Pipeline Peak 4: GI Restricted ROCK Inhibitor RXC008 for The Treatment of Fibrotic Strictures in Crohn’s Disease
Time: 9:40 am
day: Day Two
Details:
- Strictures have no current pharmaceutical treatment
- RXC008 is a potent anti-fibrotic that has the promise to be one of the first effective therapies to reverse stricture formation
- RXC008 may also protect GI tissues from inflammatory injury and enhance mucosal healing
